文献速递免疫规划卫生政策与健康促进

在巴西免疫规划中引入MenB疫苗(Bexsero)的健康影响与成本效果

Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme.
PubMed 文献 · Vaccine · 2019-09-27

本研究采用队列模型,比较巴西常规接种Bexsero疫苗与不接种两种策略。假设3剂次接种、每剂90雷亚尔、疫苗效力82.0%、接种率90.0%,估计可预防1,527例MenB病例、避免78例死亡,但每避免一个DALY的ICER为372,256雷亚尔,接种规划不太可能具有成本效果。

要点

  • 在3剂次、每剂90雷亚尔、效力82.0%、接种率90.0%的假设下,可预防1,527例MenB病例并避免78例死亡。
  • ICER为每避免一个DALY 372,256雷亚尔,接种规划不太可能具有成本效果。

核心结论

  • 在假设的接种方案与参数下,巴西引入Bexsero疫苗至免疫规划不太可能具有成本效果。

研究设计与样本

  • 采用队列模型,比较常规接种MenB疫苗与不接种两种策略。
  • 流行病学与成本估计来自巴西卫生信息系统。
  • 假设3剂次接种方案、每剂疫苗90雷亚尔、MenB疫苗效力82.0%、接种率90.0%。

主要发现

  • 估计可预防1,527例MenB病例,避免78例死亡。
  • 每避免一个DALY的ICER为372,256雷亚尔。

关键数值与推荐

  • 疫苗效力82.0%,接种率90.0%,每剂90雷亚尔,3剂次方案。
  • ICER为每避免一个DALY 372,256雷亚尔。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive meningococcal disease (IMD) is associated with a high mortality and severe sequelae. The aim of the present study was to evaluate the potential cost-effectiveness of the Bexsero vaccine in Brazil. We used a cohort model to compare routine vaccination against MenB disease with no vaccination. Epidemiological and cost estimates were obtained from the Brazilian Health Information System. The cost per disability-adjusted life year (DALY) averted and incremental cost-effectiveness ratio (ICER) was estimated assuming a 3-dose vaccination schedule, at R$90 (£ 20.50) per vaccine dose, 82.0% vaccine efficacy against MenB disease and a vaccine uptake of 90.0%. We estimated that 1,527 MenB cases would be prevented and 78 deaths averted. This strategy would cost R$ 762,381, 000 (£ 174,059,503) with a R$ 4,364,280 (£ 996,410) reduction in disease treatment costs. However, at an ICER of 372,256 (£ 84,990) per DALY averted, a vaccination programme is unlikely to be cost-effective.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Moura Silveira M, McBride AJA, Trotter CL, et al. Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme. Vaccine. 2019. PMID: 31570182. doi:10.1016/j.vaccine.2019.09.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。